According to Gram Research analysis, a 2026 systematic review of 43 clinical trials found that the ketogenic diet may help create gut bacteria conditions that improve cancer immunotherapy effectiveness, though no completed human studies have yet published results combining these two approaches. The research shows a significant increase in new trials investigating this combination since 2020, suggesting scientists believe this strategy is promising, but more evidence is needed before doctors can recommend it.
Researchers reviewed 43 clinical trials to understand how the ketogenic diet might improve cancer treatment outcomes, especially when combined with immunotherapy drugs. The diet appears to change gut bacteria in ways that could help the immune system fight cancer more effectively. While no completed studies have yet tested this combination in humans, the number of ongoing research projects investigating keto diets with immunotherapy has grown significantly since 2020. Scientists say more research is needed to confirm whether eating keto alongside cancer immunotherapy could be a helpful strategy.
Key Statistics
A 2026 systematic review of 43 clinical trials found that 47% of ketogenic diet studies in cancer care have been completed, but none have yet published results combining the diet with immunotherapy drugs.
According to research reviewed by Gram, the number of ongoing clinical trials investigating ketogenic diets combined with immunotherapy has increased significantly since 2020, with many now measuring gut bacteria changes.
A 2026 analysis of cancer nutrition research found that most existing ketogenic diet trials in oncology do not measure gut microbiome changes, making it difficult to understand how diet affects immunotherapy outcomes.
The Quick Take
- What they studied: Whether eating a ketogenic (keto) diet could help cancer immunotherapy drugs work better by changing the bacteria in your gut
- Who participated: This was a review of 43 clinical trials studying keto diets in cancer patients; no single group of patients was studied
- Key finding: 47% of the trials reviewed have finished, but none have published results yet showing keto diet combined with immunotherapy. However, many new studies started after 2020 are now investigating this combination
- What it means for you: The keto diet might become a helpful addition to cancer immunotherapy in the future, but patients should not try this without their doctor’s approval, as the evidence is still being gathered
The Research Details
Researchers looked at 43 different clinical trials that studied ketogenic diets in cancer patients. They focused on trials that measured changes in gut bacteria and how these changes might affect immunotherapy—a type of cancer treatment that helps the body’s immune system fight cancer. The review examined which trials were completed, which were still ongoing, and what they were measuring.
This type of study, called a systematic review, is like a comprehensive summary of what scientists already know about a topic. Instead of doing one new experiment, researchers carefully examine all the existing studies to see what patterns emerge. This helps identify what we know for certain and what still needs investigation.
The researchers paid special attention to trials that looked at both the keto diet and gut bacteria changes, since the connection between these two things appears to be important for how well immunotherapy works.
Understanding how diet affects gut bacteria is important because scientists have discovered that the bacteria living in your digestive system can influence how well cancer treatments work. A systematic review like this helps doctors and researchers understand the current state of knowledge before investing time and money in large new studies. It also helps identify what information is still missing.
This is a review of existing research rather than a new study with patients. The strength of the conclusions depends on the quality of the 43 trials reviewed. The fact that no completed trials have published results combining keto diet with immunotherapy means this is still very early-stage research. The increasing number of new studies starting after 2020 suggests the scientific community thinks this is a promising area worth investigating further.
What the Results Show
The review found that about half of the 43 trials studying ketogenic diets in cancer care have been completed, but importantly, none of these finished studies have yet published results that combine the keto diet with immunotherapy drugs. This is a significant finding because it means we don’t yet have human evidence showing whether this combination actually works.
However, the researchers noticed something encouraging: since 2020, there has been a major increase in new studies starting to investigate keto diets combined with immunotherapy. Many of these newer studies are also measuring changes in gut bacteria, which suggests scientists believe this connection is important.
The review suggests that the keto diet may help create conditions in the gut that could make immunotherapy more effective. This is based on laboratory studies and animal research showing that keto diets change which bacteria live in the gut, and these bacteria changes can affect how the immune system responds to cancer.
The researchers noted that many existing trials studying keto diets in cancer patients don’t measure gut bacteria at all, which makes it harder to understand the mechanism. They also found that studies vary widely in how they measure whether patients actually stick to the keto diet, making it difficult to compare results across different trials. The review highlights that future studies need to be more standardized in their approach to measuring both diet adherence and microbiome changes.
This review builds on growing evidence that gut bacteria influence cancer treatment outcomes. Previous research has shown that certain bacteria in the gut can affect how well immunotherapy works, but most of that research was done in laboratory settings or with animals. This review represents the first comprehensive look at whether the keto diet—which we know changes gut bacteria—might be a practical way to improve immunotherapy outcomes in actual cancer patients.
The biggest limitation is that no completed human trials have yet published results combining keto diet with immunotherapy, so we cannot yet say whether this approach actually works in real patients. The review only examined published or registered trials, so some ongoing research may not have been included. Additionally, the 43 trials reviewed likely vary significantly in their design, patient populations, and how they measured results, which can make it harder to draw firm conclusions. The review is also limited by the fact that most existing keto diet cancer trials don’t measure gut bacteria changes, so the connection between diet and bacteria effects remains largely theoretical at this point.
The Bottom Line
Based on current evidence, the ketogenic diet should not be used as a standalone cancer treatment or as a replacement for standard immunotherapy. However, cancer patients interested in exploring keto diet as a potential complement to immunotherapy should discuss this with their oncology team before making any dietary changes. The evidence is still preliminary (low to moderate confidence level), and more research is needed. Patients should never change their diet during cancer treatment without medical supervision.
Cancer patients undergoing immunotherapy may want to discuss this research with their doctors. Oncologists and immunotherapy specialists should be aware of this emerging research area. Researchers studying cancer treatment and nutrition should follow the growing number of trials in this space. People without cancer should not adopt a keto diet based on this research, as it’s specifically about cancer treatment.
If keto diet combined with immunotherapy proves effective, it would likely take 3-5 more years of research before results are published and another 1-2 years before doctors might routinely recommend it. This is because clinical trials take time to recruit patients, complete treatment, and analyze results. Patients should expect that any dietary changes would need to be monitored throughout their cancer treatment.
Frequently Asked Questions
Can I use a keto diet to help my cancer immunotherapy work better?
The ketogenic diet may help create beneficial gut bacteria changes that support immunotherapy, but no completed human studies have proven this yet. Always discuss any dietary changes with your oncology team before starting, as they need to monitor your overall health during cancer treatment.
How does the keto diet change gut bacteria in ways that help cancer treatment?
The ketogenic diet shifts which bacteria live in your gut by changing your food sources. Laboratory studies suggest certain bacteria changes may help your immune system recognize and fight cancer cells more effectively, though this hasn’t been confirmed in human cancer patients yet.
Are there any completed studies showing keto diet helps immunotherapy?
No completed human studies have yet published results combining ketogenic diet with cancer immunotherapy. However, 47% of the 43 trials reviewed have finished, and many new studies started after 2020 are investigating this combination with microbiome measurements.
Is it safe to try a keto diet while getting immunotherapy for cancer?
Ketogenic diets can affect nutrient absorption and energy levels, which matters during cancer treatment. Never start a keto diet during immunotherapy without explicit approval from your oncology team, as they need to monitor how it affects your treatment response and overall health.
When will doctors know if keto diet actually helps cancer immunotherapy?
Based on current research timelines, completed studies with published results may emerge within 3-5 years. Even then, doctors would need additional time to review evidence before potentially recommending it as standard practice alongside immunotherapy.
Want to Apply This Research?
- Track daily macronutrient intake (fat, protein, carbohydrates) if following a keto diet under medical supervision, recording the percentage of calories from each source to monitor diet adherence
- If approved by your oncology team, use the app to log meals and track whether you’re maintaining ketogenic macronutrient ratios (typically 70-75% fat, 20-25% protein, 5-10% carbs) while undergoing immunotherapy
- Record weekly energy levels, digestive symptoms, and any side effects alongside diet logs to help your medical team assess how the diet is affecting your overall health during cancer treatment
This review summarizes research on ketogenic diets and cancer immunotherapy, but no completed human trials have yet published results combining these approaches. This information is educational and should not replace medical advice from your oncology team. Cancer patients should never change their diet during treatment without explicit approval and supervision from their doctors. The ketogenic diet may not be appropriate for all cancer patients and could interfere with certain treatments or nutritional needs. Always consult with your healthcare provider before making dietary changes during cancer care.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.